Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 10942
  • 10943
  • 10944
  • …
  • ›
  • »

2025-03-17

Latrobe Magnesium secures hydropower allocation and Australian government funding for Sarawak project

2025-03-17

Latrobe Magnesium secures hydropower allocation and Australian government funding for Sarawak project

2025-03-17

Astral Resources declares takeover offer for Maximus Resources best and final

2025-03-17

Surefire Resources secures $439,000 R&D tax rebate

2025-03-17

Astral Resources declares takeover offer for Maximus Resources best and final

2025-03-17

Surefire Resources secures $439,000 R&D tax rebate

2025-03-16

Argent BioPharma Expands Pipeline with Promising Drug CimetrA®

2025-03-16

NAACP Backs High School Runner Who Bashed Competitor In Head With Baton

2025-03-16

X-PITCH 2023 Announces Global TOP100 Startups

2025-03-16

SINOPEC Engineering Co., Ltd: SEG Announced 2024 Annual Results Total Value of New Contracts Exceeded RMB 100 Billion With Record Dividend Payouts

2025-03-16

ArcelorMittal South Africa Seeks Cash Rescue for Mills, ST Says

2025-03-15

Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025

  • «
  • ‹
  • …
  • 10942
  • 10943
  • 10944
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 27/Apr/2026 12:21:27
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies